» Authors » James M Davis

James M Davis

Explore the profile of James M Davis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 537
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sullivan D, Golden S, Schweiger L, Melzer A, Datta S, Davis J, et al.
MDM Policy Pract . 2025 Jan; 10(1):23814683241309945. PMID: 39839686
Highlights: We evaluated patients' preferred and actual decision-making role and decisional conflict following a decision-making interaction about lung cancer screening (LCS).Concordant decision-making preference was not associated with decisional conflict.Actual decision-making...
2.
Schweiger L, Golden S, Sullivan D, Ilea I, Rice S, Melzer A, et al.
MDM Policy Pract . 2024 Nov; 9(2):23814683241286884. PMID: 39483616
Highlights: Survey of patients with a lung cancer screening (LCS) decision-making interaction.Only 44% of patients correctly answered the knowledge question about LCS.Primary LCS knowledge was not associated with decision conflict.Patient...
3.
Slatore C, Golden S, Schweiger L, Ilea I, Sullivan D, Rice S, et al.
Chest . 2024 Aug; 167(3):876-891. PMID: 39134143
Background: Many organizations recommend clinicians use structured communication processes, referred to as shared decision-making, to improve patient-reported outcomes for patients considering lung cancer screening (LCS). Research Question: Which components of...
4.
Zuo Y, Rose J, Davis J, Behrens K, Golaub A, Chandra U, et al.
Nicotine Tob Res . 2024 Apr; 26(10):1296-1304. PMID: 38654694
Introduction: This study aimed to assess the role of the rs16969968 variant of nicotinic receptor alpha-5 subunit in regulating smoking behavior and nicotine intake in response to nicotine manipulations among...
5.
Masclans L, Davis J
Public Health Pract (Oxf) . 2023 Sep; 6:100427. PMID: 37766740
Objectives: Compare financial barriers to the most effective smoking cessation medications - varenicline and combination nicotine replacement therapy (CNRT) across major insurance categories and determine whether these financial barriers impact...
6.
Davis J, Masclans L, Rose J
JAMA Netw Open . 2023 Sep; 6(9):e2332214. PMID: 37682573
Importance: Adaptive pharmacotherapy, ie, starting a medication regimen and then modifying that regimen based on patient response, is common in many medical domains but is not common in smoking cessation....
7.
Rose J, Frisbee S, Campbell D, Salley A, Claerhout S, Davis J
Psychopharmacology (Berl) . 2023 Jul; 240(9):1901-1909. PMID: 37458789
Rationale: Electronic nicotine delivery systems (ENDS) are used by smokers seeking to reduce combustible cigarette (CC) use, but the role of nicotine replacement vs. behavioral and sensory factors is still...
8.
Golden S, Schweiger L, Melzer A, Ono S, Datta S, Davis J, et al.
Prev Med Rep . 2022 Oct; 30:102014. PMID: 36237837
Few studies exist showing that involvement in lung cancer screening (LCS) leads to a change in rates of cigarette smoking. We investigated LCS longitudinally to determine whether teachable moments for...
9.
Fiore M, Smith S, Adsit R, Bolt D, Conner K, Bernstein S, et al.
PLoS One . 2022 Sep; 17(9):e0274571. PMID: 36170336
Main Objective: There is limited information on how patient outcomes have changed during the COVID-19 pandemic. This study characterizes changes in mortality, intubation, and ICU admission rates during the first...
10.
Domlyn A, Crowder C, Eisenson H, Pollak K, Davis J, Calhoun P, et al.
Front Public Health . 2022 Sep; 10:908646. PMID: 36117603
Background: Implementation mapping (IM) is a promising five-step method for guiding planning, execution, and maintenance of an innovation. Case examples are valuable for implementation practitioners to understand considerations for applying...